Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ananthakrishnan

Showing results (391-400 of 592) with videos related to

Pageof 60
Sort By:
Journal of Clinical Medicine|December 11, 2022
Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort StudyAlice Burgevin, Bénédicte Caron, Alexa Sasson, et al.
The American Journal of Gastroenterology|February 20, 2013
Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseasesEmily C Oxford, Deanna D Nguyen, Jenny Sauk, et al.
Inflammatory Bowel Diseases|June 12, 2014
Impact of mode of delivery on outcomes in patients with perianal Crohn's diseaseAlice G Cheng, Emily C Oxford, Jenny Sauk, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2024
Meta-analysis: Risk of lymphoma in patients with inflammatory bowel disease in population-based cohort studiesMohammad Zamani, Shaghayegh Alizadeh-Tabari, Mohammad Hassan Murad, et al.
Gut|January 14, 2012
Geographical variation and incidence of inflammatory bowel disease among US womenHamed Khalili, Edward S Huang, Ashwin N Ananthakrishnan, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|October 4, 2013
Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseasesZachary A Zator, Stephanie M Cantu, Gauree Gupta Konijeti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2017
Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based StudiesHai Yun Shi, Alexander N Levy, Hirsh D Trivedi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 15, 2022
Risk Factors for Incident Inflammatory Bowel Disease According to Disease PhenotypeEmily W Lopes, Paul Lochhead, Kristin E Burke, et al.
Alimentary Pharmacology & Therapeutics|February 25, 2012
Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel diseaseA N Ananthakrishnan, R Guzman-Perez, V Gainer, et al.
Inflammatory Bowel Diseases|May 12, 2016
Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease (REACH-IBD)-Promoting Improvement of Inflammatory Bowel Disease Education in the United StatesFlorian Rieder, Benjamin L Cohen, Jennifer L Dotson, et al.
Pageof 60

Showing results (391-400 of 592) with videos related to

Sort By:
Pageof 60
Journal of Clinical Medicine|December 11, 2022
Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort StudyAlice Burgevin, Bénédicte Caron, Alexa Sasson, et al.
The American Journal of Gastroenterology|February 20, 2013
Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseasesEmily C Oxford, Deanna D Nguyen, Jenny Sauk, et al.
Inflammatory Bowel Diseases|June 12, 2014
Impact of mode of delivery on outcomes in patients with perianal Crohn's diseaseAlice G Cheng, Emily C Oxford, Jenny Sauk, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2024
Meta-analysis: Risk of lymphoma in patients with inflammatory bowel disease in population-based cohort studiesMohammad Zamani, Shaghayegh Alizadeh-Tabari, Mohammad Hassan Murad, et al.
Gut|January 14, 2012
Geographical variation and incidence of inflammatory bowel disease among US womenHamed Khalili, Edward S Huang, Ashwin N Ananthakrishnan, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|October 4, 2013
Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseasesZachary A Zator, Stephanie M Cantu, Gauree Gupta Konijeti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2017
Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based StudiesHai Yun Shi, Alexander N Levy, Hirsh D Trivedi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 15, 2022
Risk Factors for Incident Inflammatory Bowel Disease According to Disease PhenotypeEmily W Lopes, Paul Lochhead, Kristin E Burke, et al.
Alimentary Pharmacology & Therapeutics|February 25, 2012
Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel diseaseA N Ananthakrishnan, R Guzman-Perez, V Gainer, et al.
Inflammatory Bowel Diseases|May 12, 2016
Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease (REACH-IBD)-Promoting Improvement of Inflammatory Bowel Disease Education in the United StatesFlorian Rieder, Benjamin L Cohen, Jennifer L Dotson, et al.
Pageof 60